The Rationale for Performing Autologous Peripheral Blood Stem Cell Transplants in Community Cancer Centers

Oncologist - United States
doi 10.1634/theoncologist.3-5-346
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

The Rationale for Not Routinely Purging Autologous Blood Stem Cell Grafts

Hematology
Hematology
1998English

Acute Quadriplegic Myopathy Following Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer

Bone Marrow Transplantation
TransplantationHematology
1999English

Autoreactive Antibodies Following Autologous Peripheral Blood Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
1998English

Tumor Cell Contamination of Peripheral Blood Stem Cell Transplants and Bone Marrow in High-Risk Breast Cancer Patients

Bone Marrow Transplantation
TransplantationHematology
1997English

Strongyloidiasis Pre and Post Autologous Peripheral Blood Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2003English

Ulcerative Colitis After Autologous Peripheral Blood Stem Cell Transplantation for Non-Hodgkin’s Lymphoma

Bone Marrow Transplantation
TransplantationHematology
2001English

Autologous Peripheral Blood Stem Cell Transplantation for Peripheral Neuropathy Secondary to Monoclonal Gammopathy of Unknown Significance

Bone Marrow Transplantation
TransplantationHematology
2002English

Autologous Peripheral Blood Stem Cell Transplantation for Adult Patients With B-Cell Lymphoma-Associated Hemophagocytic Syndrome

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2001English

Autologous Peripheral Blood Stem Cell Transplantation in Children and Adolescents With Non‑Hodgkin Lymphoma

Oncology Letters
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy